How to face the association between tobacco and psychosis?
Evidences suggest an association between tobacco and psychosis. However, the reasons why people with psychosis have a higher tendency to smoke than the general population are not yet clear. Recently, Gurillo et al. reported that daily use of tobacco is associated with an increased risk of psychotic disorder and an earlier age of onset of psychotic illness. His study also calculated a significant mean difference in age at onset, expressed in years, and estimated the prevalence of smoking in people with their first episode of psychosis. According to this and other findings, it could be said that the causes of the smoking-schizophrenia association are complex and cannot be explained solely as a result of some aspect of schizophrenia. Thus, new studies in this area are needed, as well as strategies that look for the monitoring of smoking effects in order to reduce it among individuals with schizophrenia.
Key-words: Tobacco, Psychosis, Illness.
2 Jiang J, See YM, Subramaniam M, Lee J. Investigation of cigarette smoking among male schizophrenia patients. PLoS One 2013; 8: e71343.
3 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Ahnallen CG. Separate and combined eff ects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine Tob Res 2013; 15: 121–29.
4 Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980–2012. JAMA 2014; 311: 183–92.
5 Gurillo P, Jauhar S, Murray RM, MacCabe JH. Does tobacco use cause psychosis? Systematic review and meta-analysis. Lancet Psychiatry 2015; 2: 718–25
6 Zhang XY, Chen DC, Xiu MH, et al. Cigarette smoking, psychopathology and cognitive function in fi rst-episode drug-naïve patients with schizophrenia: a case-control study. Psychol Med 2013; 43: 1651–60.
7 Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biol Psychiatry 2013; 74: 436–43.
8 Sara G, Burgess P, Malhi GS, Whiteford H, Hall W. Diff erences in associations between cannabis and stimulant disorders in first admission psychosis. Schizophr Res 2013; 147: 216–22.
9 deRuiter WK, Cheng C, Gehrs M, Langley J, Dewa CS. Substance abuse and smoking among a Canadian cohort of fi rst episode psychosis patients. Community Ment Health J 2013; 49: 815–21.
10 Petrovsky N, Ettinger U, Quednow BB, et al. Nicotine enhances antisaccade performance in schizophrenia patients and healthy controls. Int J Neuropsychopharmacol 2013; 16: 1473–81.
Copyright policies & self-archiving
We are a RoMEO green journal.
Author's Pre-print: author can archive pre-print (ie pre-refereeing)
Author's Post-print: author can archive post-print (ie final draft post-refereeing)
Publisher's Version/PDF: author can archive publisher's version/PDF
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 4.0 License ©